SRNE — Sorrento Therapeutics, Inc.

SRNESorrento Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · sorrentotherapeutics.com

0.0005USD0.00%Mkt Cap: 275640 USDP/E: —Last update: 2026-05-25

Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company, provides therapeutic solutions in the United States and internationally. It offers chimeric antigen receptor T-cell therapy, dimeric…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap275.64K USD

Enterprise Value134.39M USD

Revenue (TTM)64.27M USD

Gross Profit29.39M USD

Net Income (TTM)-572.84M USD

Revenue/Share0.1270 USD

Last Price0.0005 USD

Fiscal Year EndDec 2022

MR QuarterJun 2023

Employees949

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-0.39

EV/Revenue2.09

P/S0.00

P/B-0.00

EPS (TTM)-0.09

EPS (Forward)—

52W Range

0.00020% of range0.0985

52W High0.0985 USD

52W Low0.0002 USD

Profitability

Gross Margin46.77%

Oper. Margin-510.93%

EBITDA Margin0.00%

Profit Margin-911.60%

ROE3078.97%

ROA-121.15%

Growth

Revenue Growth31.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF-293.86M USD

CapEx (TTM)13.66M USD

FCF Margin-89.51%

FCF Yield-20871.25%

Net Debt126.97M USD

Net Debt/EBITDA-0.37

Balance Sheet

Debt/Equity-7.23

Current Ratio0.41

Quick Ratio0.34

Book Value/Sh-0.3770 USD

Cash/Share0.1480 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:25

Split DateAug 1, 2013

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.551.28M

Float539.11M

Insiders0.00%

Institutions0.06%

Short Interest

Short Ratio5.0d

Short % Float11.96%

Short % Out.11.84%

Shares Short64.56M

Short (prev mo.)61.44M

Technical

SMA 500.0017 (-70.5%)

SMA 2000.0036 (-86.2%)

Beta0.31

S&P 52W Chg28.31%

Avg Vol (30d)164.15K

Avg Vol (10d)172.94K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—